
Pubmed-entry ::= {
  pmid 29330034,
  medent {
    em std {
      year 2018,
      month 1,
      day 14,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Successful treatment of a penicillin-intermediate and
 ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve
 endocarditis with vancomycin."
      },
      authors {
        names std {
          {
            name ml "Jones BM",
            affil str "St. Joseph's/Candler Health System, Inc., 5353 Reynolds
 Street, Savannah, GA 31405. Electronic address: jonesbru@sjchs.org."
          },
          {
            name ml "Hersey RM",
            affil str "St. Joseph's/Candler Health System, Inc., 5353 Reynolds
 Street, Savannah, GA 31405."
          },
          {
            name ml "Trestman IJ",
            affil str "St. Joseph's/Candler Health System, Inc., 5353 Reynolds
 Street, Savannah, GA 31405."
          },
          {
            name ml "Bland CM",
            affil str "University of Georgia College of Pharmacy, St. Joseph
's/Candler Health System, Inc., Savannah, GA."
          }
        }
      },
      from journal {
        title {
          iso-jta "Int. J. Antimicrob. Agents",
          ml-jta "Int J Antimicrob Agents",
          issn "1872-7913",
          name "International journal of antimicrobial agents"
        },
        imp {
          date std {
            year 2018,
            month 3
          },
          volume "51",
          issue "3",
          pages "508-510",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 10,
                day 31
              }
            },
            {
              pubstatus revised,
              date std {
                year 2017,
                month 12,
                day 27
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2017,
                month 12,
                day 30
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 1,
                day 14,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 8,
                day 25,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 1,
                day 14,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29330034,
        pii "S0924-8579(18)30002-5",
        doi "10.1016/j.ijantimicag.2017.12.031",
        other {
          db "ELocationID pii",
          tag str "S0924-8579(18)30002-5"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.ijantimicag.2017.12.031"
        }
      }
    },
    abstract "Advancements in rapid diagnostics have helped to identify
 nutritionally variant streptococci (NVS) as an increasing cause of infective
 endocarditis (IE). This case report highlights the challenges in
 susceptibility testing and the importance of appropriate empiric treatment
 for Granulicatella adiacens, and provides considerations for future practice
 guideline recommendations. Guidelines for treatment of IE caused by NVS are
 currently limited to patients with native valve disease. We present a patient
 with presumed prosthetic valve endocarditis caused by G. adiacens, with
 clinically relevant resistance to recommended first-line agents (penicillin
 and ceftriaxone), who was successfully treated with 8 weeks of intravenous
 (IV) vancomycin. Vancomycin is currently recommended as an alternate therapy
 for patients intolerant of penicillins, but we believe vancomycin should be
 considered a first-line empiric treatment option for IE when the identified
 organism is G. adiacens and susceptibility testing is not readily available.",
    mesh {
      {
        term "Administration, Intravenous"
      },
      {
        term "Aged"
      },
      {
        term "Anti-Bacterial Agents",
        qual {
          {
            mp TRUE,
            subh "administration & dosage"
          }
        }
      },
      {
        term "Carnobacteriaceae",
        qual {
          {
            subh "drug effects"
          },
          {
            mp TRUE,
            subh "isolation & purification"
          }
        }
      },
      {
        term "Ceftriaxone",
        qual {
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "Endocarditis, Bacterial",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            subh "microbiology"
          }
        }
      },
      {
        term "Gram-Positive Bacterial Infections",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            subh "microbiology"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Male"
      },
      {
        term "Penicillins",
        qual {
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "Prosthesis-Related Infections",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            subh "microbiology"
          }
        }
      },
      {
        term "Treatment Outcome"
      },
      {
        term "Vancomycin",
        qual {
          {
            mp TRUE,
            subh "administration & dosage"
          }
        }
      },
      {
        term "beta-Lactam Resistance"
      }
    },
    substance {
      {
        type nameonly,
        name "Anti-Bacterial Agents"
      },
      {
        type nameonly,
        name "Penicillins"
      },
      {
        type cas,
        cit "6Q205EH1VU",
        name "Vancomycin"
      },
      {
        type cas,
        cit "75J73V1629",
        name "Ceftriaxone"
      }
    },
    pmid 29330034,
    pub-type {
      "Case Reports",
      "Journal Article"
    },
    status medline
  }
}


